The pharmacologic treatment of Dravet syndrome

Epilepsia

Volumn 52, Issue SUPPL. 2, 2011, Pages 72-75

  Chiron, Catherine ^a,b,c   Dulac, Olivier ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Child; Dravet syndrome; Epilepsy; Stiripentol; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; ACETAZOLAMIDE; ALLOPURINOL; BROMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CLORAZEPATE; CYTOCHROME P450; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; MESUXIMIDE; MIDAZOLAM; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PLACEBO; STIRIPENTOL; SULTIAME; THIOPENTAL; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ACNE; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG MEGADOSE; EPILEPTIC STATE; FATIGUE; FEBRILE CONVULSION; HUMAN; KETOGENIC DIET; LENNOX GASTAUT SYNDROME; LIVER FAILURE; MYOCLONUS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SIDE EFFECT; TONIC CLONIC SEIZURE; WEIGHT REDUCTION;

ANTICONVULSANTS; EPILEPSIES, MYOCLONIC; FRUCTOSE; HUMANS; KETOGENIC DIET; SYNDROME; TREATMENT OUTCOME;

EID: 79953685960     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03007.x     Document Type: Article

References (24)

1. Camfield C, Camfield P, Smith E, Tibbles JA,. (1986) Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver blood or renal damage. Neurology 36: 838-841. (Pubitemid 16056227)
2. Chipaux M, Villeneuve N, Sabouraud P, Desguerre I, Boddaert N, Depienne C, Chiron C, Dulac O, Nabbout R,. (2010) Unusual consequences of status epilepticus in Dravet syndrome. Seizure 19: 190-194.
3. Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G,. (2000) Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial, STICLO study group. Lancet 356: 1638-1642.
4. Coppola G, Capovilla G, Montagnini A, Romeo A, Spano M, Tortorella G, Veggiotti P, Viri M, Pascotto A,. (2002) Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49: 45-48. (Pubitemid 34304205)
5. Dravet C, Bureau M,. (2008) Severe Myoclonic Epilepsy in Infancy (Dravet syndrome). In, Engel J, Pedley TA, (Eds) Epilepsy, a comprehensive textbook. 2nd ed. Lippincott Williams Wilkins, Philadelphia, pp. 2337-2342.
6. Ernst JP, Doose H, Baier WK,. (1988) Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev 10: 385-388. (Pubitemid 19013892)
7. Fisher JL,. (2009) The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator. Neuropharmacology 56: 190-197.
8. Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A,. (2006) In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metab Dispos 34: 608-611.
9. Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z,. (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66: 1654-1660. (Pubitemid 43964617)
10. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O,. (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512. (Pubitemid 28221807)
11. Inoue Y, Ohtsuka Y, Oguni H, Tohyama J, Baba H, Fukushima K, Ohtani H, Takahashi Y, Ikeda S,. (2009) Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 50: 2362-2368.
12. Kassai B, Chiron C, Augier S, Cucherat M, Rey E, Guerrini R, Vincent J, Dulac O, Pons G,. (2008) Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia 49: 343-348. (Pubitemid 351172001)
13. Kroll-Seger J, Portilla P, Dulac O, Chiron C,. (2006) Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 37: 325-329. (Pubitemid 46480526)
14. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P,. (1997) Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome, Lamictal Lennox-Gastaut Study Group. N Engl J Med 337: 1807-1812. (Pubitemid 28006785)
15. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR,. (2000) Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 9: 590-594. (Pubitemid 32094376)
16. Oakley JC, Kalume F, Yu FH, Scheuer T, Catterall WA,. (2009) Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. Proc Natl Acad Sci USA 106: 3994-3999.
17. Perez J, Chiron C, Musial C, Rey E, Blehaut H, d'Athis P, Vincent J, Dulac O,. (1999) Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia 40: 1618-1626. (Pubitemid 29518093)
18. Quilichini PP, Diabira D, Chiron C, Milh M, Ben Ari Y, Gozlan H,. (2003) Effects of antiepileptic drugs on refractory seizures in the intact immature cortico-hippocampal formation in vitro. Epilepsia 44: 1365-1374. (Pubitemid 37385843)
19. Quilichini PP, Chiron C, Ben-Ari Y, Gozlan H,. (2006) Stiripentol a putative antiepileptic drug enhances the duration of opening of GABA-receptor channels. Epilepsia 47: 704-716.
20. Rantala H, Tarkka R, Uhari M,. (1997) A meta-analytic review of the preventive treatment of recurrences of febrile seizures. J Pediatr 131: 922-925. (Pubitemid 28027622)
21. Striano P, Coppola G, Pezella M, Ciampa C, Specchio N, Ragona F, Mancardi MM, Gennaro E, Beccaria F, Capovilla G, Rasmini P, Besana D, Coppola G, Elia M, Granata T, Vecchi M, Vigevano F, Viri M, Gaggero R, Striano S, Zara F,. (2007) An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69: 250-254. (Pubitemid 47205686)
22. Tanabe T, Awaya Y, Matsuishi T, Iyoda K, Nagai T, Kurihara M, Yamamoto K, Minagawa K, Maekawa K,. (2008) Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)-a nationwide questionnaire survey in Japan. Brain Dev 30: 629-635.
23. Thanh TN, Chiron C, Dellatolas G, Rey E, Pons G, Vincent J, Dulac O,. (2002) Efficacy and tolerability of stiripentol in the treatment of severe myoclonic epilepsy in infancy (Dravet syndrome). Arch Pediatr 9: 1120-1127. (Pubitemid 35429290)
24. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA,. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9: 1142-1149. (Pubitemid 44306307)